結果ページ13 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (656)
- オーストラリア (49)
- オーストリア (11)
- ベルギー (6)
- ブラジル (14)
- カナダ (48)
- 中国 (91)
- デンマーク (5)
- フィンランド (4)
- フランス (27)
- ドイツ (449)
- 香港 (46)
- インド (19)
- イスラエル (12)
- イタリア (3)
- 日本 (37)
- メキシコ (22)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (2)
- 韓国 (20)
- スペイン (4)
- スウェーデン (55)
- スイス (8)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (24)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (49)
- Brussels (6)
- BSE (9)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (5)
- Frankfurt (395)
- Helsinki (4)
- HKSE (46)
- IOB (24)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (22)
- Milan (3)
- Munich (17)
- NSE (10)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (41)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (6)
- Paris (27)
- São Paulo (14)
- Shanghai (46)
- Shenzhen (45)
- Stockholm (55)
- Stuttgart (24)
- Swiss (8)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (156)
- Tech Market Middle (85)
- Tech Market Small (211)
- Tel Aviv (12)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (13)
バイオテクノロジー (1697)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $3.41 — | $3.41 — | $583.10M — | 0 | -$1.06 — | ||
| REGENXBIO Inc. RB0.F | €10.50 11.48 USD |
+2.94
|
€531.54M 581.05M USD | €700.00 765.19 USD | €10.50 11.48 USD | €10.50 11.48 USD | €531.54M 581.05M USD | 0 | -€3.01 -3.2 USD | ||
| Zota Health Care Limited ZOTA.NS | ₹1,568.30 18.97 USD |
-3.71
|
₹47.57B 575.53M USD | ₹118.56K 1.43K USD | ₹1,533.50 18.55 USD | ₹1,627.20 19.69 USD | ₹47.57B 575.53M USD | 0 | -₹21.50 -0.2 USD | ||
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | ||
| Viva Biotech Holdings VBIZF | $0.26 — |
0
|
$556.10M — | $100.00 — | $0.29 — | $0.29 — | $556.10M — | 26.35 | $0.01 — | ||
| Opthea Limited OPT.AX | A$0.60 0.4 USD |
0
|
A$820.79M 543.24M USD | A$6.21M 4.11M USD | A$0.60 0.39 USD | A$0.62 0.41 USD | A$820.79M 543.24M USD | 0 | -A$0.43 -0.2 USD | ||
| Prestige BioPharma Limited 950210.KS | ₩11,820 8.92 USD |
+0.17
|
₩710B 536.19M USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩710B 536.19M USD | 0 | ₩0 0 USD | ||
| Green Cross Holdings Corporation 005250.KS | ₩15,380 11.61 USD |
-1.66
|
₩709B 535.51M USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩709B 535.51M USD | 0 | ₩0 0 USD | ||
| Prothena Corporation plc 0PT.F | €8.90 9.73 USD |
+1.71
|
€489.10M 534.65M USD | €250.00 273.28 USD | €8.85 9.67 USD | €8.90 9.73 USD | €489.10M 534.65M USD | 0 | -€4.52 -4.9 USD | ||
| NovaBridge Biosciences IMAB | $4.63 — |
0
|
$533.68M — | $0.00 — | $0.00 — | $0.00 — | $533.68M — | 0 | $0.00 — | ||
| Niagen Bioscience, Inc. OCD1.F | €6.05 6.61 USD |
+6.14
|
€484.23M 529.33M USD | €1.00K 1.09K USD | €5.65 6.18 USD | €6.05 6.61 USD | €484.23M 529.33M USD | 28.80 | €0.21 0.23 USD | ||
| Nxera Pharma Co., Ltd. 4565.T | ¥857 5.78 USD |
-0.58
|
¥78B 523.51M USD | ¥432K 2.92K USD | ¥855 5.77 USD | ¥877 5.92 USD | ¥78B 523.51M USD | 0 | -¥36 -0.2 USD | ||
| Cellectis S.A. ZVA.F | €4.64 5.07 USD |
+11.28
|
€473.45M 517.54M USD | €1.25K 1.37K USD | €4.64 5.07 USD | €4.64 5.07 USD | €473.45M 517.54M USD | 0 | -€0.28 -0.3 USD | ||
| Altimmune, Inc. ALT1.MX | MX$83.00 4.91 USD |
0
|
MX$8.66B 512.8M USD | MX$0.00 0 USD | MX$83.00 4.91 USD | MX$83.00 4.91 USD | MX$8.66B 512.8M USD | 0 | -MX$19.76 -1.1 USD | ||
| Altimmune, Inc. 3G0.F | €4.33 4.73 USD |
+6.34
|
€451.59M 493.65M USD | €110.00 120.24 USD | €4.33 4.73 USD | €4.33 4.73 USD | €451.59M 493.65M USD | 0 | -€0.93 -1.01 USD | ||
| Cellectis S.A. ZVAA.F | €4.34 4.74 USD |
+6.9
|
€450.75M 492.73M USD | €6.70K 7.32K USD | €4.34 4.74 USD | €4.58 5.01 USD | €450.75M 492.73M USD | 0 | -€0.28 -0.3 USD | ||
| Viva Biotech Holdings VB0.F | €0.21 0.23 USD |
0
|
€447.29M 488.95M USD | €1.26K 1.38K USD | €0.21 0.23 USD | €0.21 0.23 USD | €447.29M 488.95M USD | 20.60 | €0.01 0.01 USD | ||
| Nxera Pharma SOLTF | $5.37 — |
0
|
$485.96M — | $1.20K — | $5.54 — | $5.60 — | $485.96M — | 0 | -$0.23 — | ||
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | ||
| Nxera Pharma Co., Ltd. JSS.F | €4.64 5.07 USD |
-0.43
|
€428.17M 468.05M USD | €400.00 437.25 USD | €4.64 5.07 USD | €4.64 5.07 USD | €428.17M 468.05M USD | 0 | -€0.20 -0.2 USD | ||
| Formycon AG FYB.F | €23.95 26.18 USD |
+6.44
|
€423.06M 462.47M USD | €1.62K 1.77K USD | €22.60 24.7 USD | €23.95 26.18 USD | €423.06M 462.47M USD | 0 | -€9.67 -10.5 USD | ||
| Zevra Therapeutics, Inc. 1GDA.F | €7.40 8.09 USD |
-2.63
|
€422.92M 462.31M USD | €2.12K 2.32K USD | €7.40 8.09 USD | €7.40 8.09 USD | €422.92M 462.31M USD | 18.04 | €0.41 0.45 USD | ||
| DBV Technologies S.A. DBV.F | €2.35 2.56 USD |
+0.43
|
€422.07M 461.38M USD | €1.40K 1.53K USD | €2.35 2.56 USD | €2.35 2.56 USD | €422.07M 461.38M USD | 0 | -€0.90 -0.9 USD | ||
| Dishman Carbogen Amcis Limited DCAL.NS | ₹240.00 2.9 USD |
+3.69
|
₹37.74B 456.64M USD | ₹196.36K 2.38K USD | ₹230.00 2.78 USD | ₹242.15 2.93 USD | ₹37.74B 456.64M USD | 27.58 | ₹8.70 0.11 USD | ||
| Dishman Carbogen Amcis Limited DCAL.BO | ₹240.55 2.91 USD |
+3.64
|
₹37.71B 456.28M USD | ₹11.77K 142.45 USD | ₹230.00 2.78 USD | ₹242.00 2.93 USD | ₹37.71B 456.28M USD | 27.64 | ₹8.70 0.11 USD | ||
| Cellectis S.A. CMVLF | $4.50 — |
0
|
$451.46M — | $2.00K — | $4.50 — | $4.50 — | $451.46M — | 0 | -$0.33 — | ||
| Bright Minds Biosciences Inc. DRUG.CN | CA$85.50 63.45 USD |
0
|
CA$606.08M 449.75M USD | CA$1.24K 916.44 USD | CA$85.36 63.34 USD | CA$85.50 63.45 USD | CA$606.08M 449.75M USD | 0 | -CA$1.37 -1.01 USD | ||
| Bicycle Therapeutics plc 50BA.F | €5.60 6.12 USD |
+4.67
|
€410.55M 448.79M USD | €20.00 21.86 USD | €5.55 6.07 USD | €5.60 6.12 USD | €410.55M 448.79M USD | 0 | -€3.15 -3.4 USD | ||
| NovaBridge Biosciences 0VY.F | €3.40 3.72 USD |
-5.56
|
€391.90M 428.4M USD | €1.00K 1.09K USD | €3.40 3.72 USD | €3.40 3.72 USD | €391.90M 428.4M USD | 0 | -€0.44 -0.4 USD | ||
| Avacta AVCTF | $0.97 — |
-7.81
|
$419.79M — | $26.00K — | $0.96 — | $1.05 — | $419.79M — | 0 | -$0.14 — | ||
| Avacta Group Plc RTQ1.F | €0.81 0.89 USD |
-5.81
|
€374.24M 409.1M USD | €6.00K 6.56K USD | €0.81 0.89 USD | €0.81 0.89 USD | €374.24M 409.1M USD | 0 | -€0.13 -0.1 USD | ||
| PureTech Health PTCHF | $1.68 — |
0
|
$406.03M — | $1.00K — | $1.70 — | $1.70 — | $406.03M — | 9.88 | $0.17 — | ||
| Ocugen, Inc. OCGN.MX | MX$21.00 1.24 USD |
0
|
MX$6.84B 405.3M USD | MX$0.00 0 USD | MX$21.00 1.24 USD | MX$21.00 1.24 USD | MX$6.84B 405.3M USD | 0 | -MX$4.07 -0.2 USD | ||
| Clinuvel Pharmaceuticals CLVLF | $7.56 — |
0
|
$401.73M — | $100.00 — | $7.56 — | $7.56 — | $401.73M — | 16.43 | $0.46 — | ||
| Newron Pharmaceuticals S.p.A. NP5.F | €18.40 20.11 USD |
+5.02
|
€367.28M 401.49M USD | €1.06K 1.16K USD | €18.14 19.83 USD | €18.40 20.11 USD | €367.28M 401.49M USD | 13.52 | €1.36 1.49 USD | ||
| Akebia Therapeutics, Inc. AX9.F | €1.36 1.49 USD |
+3.57
|
€361.43M 395.09M USD | €100.00 109.31 USD | €1.36 1.49 USD | €1.36 1.49 USD | €361.43M 395.09M USD | 0 | -€0.07 -0.07 USD | ||
| Autolus Therapeutics plc 6A3A.F | €1.18 1.29 USD |
+11.32
|
€354.46M 387.47M USD | €1.00K 1.09K USD | €1.06 1.16 USD | €1.18 1.29 USD | €354.46M 387.47M USD | 0 | -€0.72 -0.7 USD | ||
| PureTech Health PRTC | $15.99 — |
+0.38
|
$386.45M — | $5.11K — | $15.80 — | $16.24 — | $386.45M — | 9.40 | $1.70 — | ||
| Enanta Pharmaceuticals, Inc. 9EP.F | €11.60 12.68 USD |
0
|
€339.59M 371.22M USD | €54.00 59.03 USD | €11.10 12.13 USD | €11.70 12.79 USD | €339.59M 371.22M USD | 0 | -€3.34 -3.6 USD | ||
| XOMA Royalty Corporation X0M1.F | €26.80 29.3 USD |
-0.74
|
€331.87M 362.78M USD | €13.00 14.21 USD | €26.80 29.3 USD | €26.80 29.3 USD | €331.87M 362.78M USD | 41.23 | €0.65 0.71 USD | ||
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | ||
| Galectin Therapeutics Inc. PHPN.F | €4.74 5.18 USD |
+3.04
|
€321.55M 351.5M USD | €2.00K 2.19K USD | €4.74 5.18 USD | €5.00 5.47 USD | €321.55M 351.5M USD | 0 | -€0.51 -0.5 USD | ||
| Clinuvel Pharmaceuticals Limited UR9.F | €6.18 6.76 USD |
+1.81
|
€319.42M 349.17M USD | €372.00 406.65 USD | €6.11 6.68 USD | €6.18 6.76 USD | €319.42M 349.17M USD | 15.44 | €0.40 0.44 USD | ||
| PureTech Health plc 0VQ0.F | €12.90 14.1 USD |
+2.38
|
€311.77M 340.81M USD | €0.00 0 USD | €12.90 14.1 USD | €12.90 14.1 USD | €311.77M 340.81M USD | 8.71 | €1.48 1.62 USD | ||
| Clinuvel Pharmaceuticals Limited UR9A.F | €5.90 6.45 USD |
0
|
€304.95M 333.35M USD | €1.68K 1.84K USD | €5.90 6.45 USD | €5.90 6.45 USD | €304.95M 333.35M USD | 14.75 | €0.40 0.44 USD | ||
| Healios K.K. 6VX.F | €2.48 2.71 USD |
-2.36
|
€296.99M 324.65M USD | €350.00 382.6 USD | €2.48 2.71 USD | €2.48 2.71 USD | €296.99M 324.65M USD | 0 | -€0.34 -0.3 USD | ||
| Antengene Corporation Limited 722.F | €0.47 0.51 USD |
+0.43
|
€296.11M 323.68M USD | €103.00 112.59 USD | €0.47 0.51 USD | €0.47 0.51 USD | €296.11M 323.68M USD | 0 | -€0.04 -0.04 USD | ||
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.43 2.65 USD |
+1.17
|
€287.11M 313.85M USD | €3.00 3.28 USD | €2.43 2.65 USD | €2.43 2.65 USD | €287.11M 313.85M USD | 0 | -€1.96 -2.1 USD | ||
| Gongwin Biopharm Holdings Co., Ltd. 6617.TWO | NT$79.40 2.52 USD |
-3.17
|
NT$9.74B 309.37M USD | NT$137.18K 4.36K USD | NT$79.30 2.52 USD | NT$81.60 2.59 USD | NT$9.74B 309.37M USD | 0 | -NT$0.71 -0.02 USD | ||
| Avalo Therapeutics Inc. R C6K0.F | €15.40 16.83 USD |
-1.91
|
€279.26M 305.27M USD | €496.00 542.2 USD | €15.40 16.83 USD | €15.40 16.83 USD | €279.26M 305.27M USD | 0 | -€11.66 -12.7 USD | ||
| Frontage FGHQF | $0.15 — |
0
|
$303.75M — | $130.00 — | $0.15 — | $0.15 — | $303.75M — | 0 | $0.00 — | ||
| Aldeyra Therapeutics, Inc. 137.F | €4.52 4.94 USD |
-0.11
|
€272.00M 297.33M USD | €540.00 590.29 USD | €4.47 4.88 USD | €4.60 5.03 USD | €272.00M 297.33M USD | 0 | -€0.63 -0.6 USD | ||
| Larimar Therapeutics, Inc. ZA71.F | €3.10 3.39 USD |
+1.31
|
€269.01M 294.07M USD | €510.00 557.5 USD | €3.10 3.39 USD | €3.10 3.39 USD | €269.01M 294.07M USD | 0 | -€1.70 -1.8 USD | ||
| Astria Therapeutics, Inc. 2090.MU | €4.74 5.18 USD |
0
|
€267.40M 292.3M USD | €108.00 118.06 USD | €4.74 5.18 USD | €4.74 5.18 USD | €267.40M 292.3M USD | 0 | -€44.71 -48.8 USD | ||
| Hansa Biopharma AB (publ) HNSBF | $2.91 — |
0
|
$290.20M — | $150.00 — | $2.93 — | $2.93 — | $290.20M — | 0 | -$0.95 — | ||
| Hansa Biopharma AB (publ) 24H.F | €2.51 2.74 USD |
+2.62
|
€264.36M 288.98M USD | €30.40K 33.23K USD | €2.51 2.74 USD | €2.51 2.74 USD | €264.36M 288.98M USD | 0 | -€0.83 -0.9 USD | ||
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | ||
| AC Immune SA IMR.F | €2.59 2.83 USD |
+2.57
|
€260.55M 284.82M USD | €2.00K 2.19K USD | €2.59 2.83 USD | €2.59 2.83 USD | €260.55M 284.82M USD | 0 | -€0.77 -0.8 USD | ||
| Fennec Pharmaceuticals Inc. FRX.TO | CA$11.22 8.33 USD |
+2.75
|
CA$383.20M 284.36M USD | CA$401.00 297.57 USD | CA$11.17 8.29 USD | CA$11.22 8.33 USD | CA$383.20M 284.36M USD | 0 | -CA$0.37 -0.2 USD | ||
| Vanda Pharmaceuticals Inc. VM4.F | €4.18 4.57 USD |
+1.46
|
€256.20M 280.06M USD | €533.00 582.64 USD | €4.18 4.57 USD | €4.18 4.57 USD | €256.20M 280.06M USD | 0 | -€1.25 -1.3 USD | ||
| Mereo BioPharma Group plc MAH0.F | €1.60 1.74 USD |
+4.25
|
€253.82M 277.45M USD | €1.45K 1.59K USD | €1.52 1.66 USD | €1.60 1.74 USD | €253.82M 277.45M USD | 0 | -€0.22 -0.2 USD | ||
| Protara Therapeutics, Inc. 1KPA.F | €6.50 7.11 USD |
+4
|
€250.82M 274.18M USD | €27.00 29.51 USD | €6.30 6.89 USD | €6.50 7.11 USD | €250.82M 274.18M USD | 0 | -€1.21 -1.3 USD | ||
| Anavex Life Sciences Corp. 12X1.F | €2.87 3.14 USD |
-2.05
|
€246.52M 269.47M USD | €2.00K 2.19K USD | €2.58 2.81 USD | €2.87 3.14 USD | €246.52M 269.47M USD | 0 | -€0.50 -0.5 USD | ||
| Silence Therapeutics plc XRP2.F | €5.20 5.68 USD |
-0.95
|
€245.62M 268.49M USD | €50.00 54.66 USD | €5.20 5.68 USD | €5.20 5.68 USD | €245.62M 268.49M USD | 0 | -€1.17 -1.2 USD | ||
| Oryzon Genomics S.A. ORN.F | €3.05 3.33 USD |
+5
|
€244.31M 267.06M USD | €50.00 54.66 USD | €3.05 3.33 USD | €3.05 3.33 USD | €244.31M 267.06M USD | 0 | -€0.06 -0.06 USD | ||
| Oryzon Genomics ORYZF | $3.36 — |
0
|
$264.95M — | $5.00K — | $3.03 — | $3.03 — | $264.95M — | 0 | -$0.07 — | ||
| Immutep PRRUF | $0.18 — |
0
|
$264.95M — | $2.50K — | $0.22 — | $0.22 — | $264.95M — | 0 | -$0.02 — | ||
| Onward Medical N.V. 63E.F | €4.25 4.65 USD |
-1.28
|
€240.04M 262.39M USD | €140.00 153.04 USD | €4.25 4.65 USD | €4.51 4.93 USD | €240.04M 262.39M USD | 0 | -€0.74 -0.8 USD | ||
| Mereo BioPharma Group plc MAH0.SG | €1.50 1.64 USD |
-0.66
|
€238.70M 260.93M USD | €0.00 0 USD | €1.50 1.63 USD | €1.53 1.67 USD | €238.70M 260.93M USD | 0 | -€0.22 -0.2 USD | ||
| Voyager Therapeutics, Inc. VYGR.MX | MX$78.50 4.65 USD |
0
|
MX$4.36B 258.44M USD | MX$0.00 0 USD | MX$78.50 4.65 USD | MX$78.50 4.65 USD | MX$4.36B 258.44M USD | 0 | -MX$40.10 -2.3 USD | ||
| Fennec Pharmaceuticals Inc. RV41.F | €6.90 7.54 USD |
+2.99
|
€235.66M 257.61M USD | €0.00 0 USD | €6.45 7.05 USD | €6.90 7.54 USD | €235.66M 257.61M USD | 0 | -€0.23 -0.2 USD | ||
| Panacea Biotec Limited PANACEABIO.NS | ₹345.15 4.18 USD |
-0.35
|
₹21.14B 255.77M USD | ₹90.72K 1.1K USD | ₹342.50 4.14 USD | ₹350.00 4.23 USD | ₹21.14B 255.77M USD | 0 | -₹1.18 -0.01 USD | ||
| Silence Therapeutics SLNCF | $1.80 — |
+12.5
|
$255.06M — | $600.00 — | $1.80 — | $1.80 — | $255.06M — | 0 | -$0.45 — | ||
| Panacea Biotec Limited PANACEABIO.BO | ₹344.05 4.16 USD |
-1.29
|
₹21.07B 254.95M USD | ₹2.18K 26.4 USD | ₹343.00 4.15 USD | ₹350.95 4.25 USD | ₹21.07B 254.95M USD | 0 | -₹1.19 -0.01 USD | ||
| Saniona AB (publ) 30S.F | €1.43 1.56 USD |
+0.42
|
€230.06M 251.49M USD | €110.00 120.24 USD | €1.43 1.56 USD | €1.43 1.56 USD | €230.06M 251.49M USD | 7.93 | €0.18 0.2 USD | ||
| Vicore Pharma Holding AB (publ) 6Y4.F | €0.93 1.02 USD |
+2.75
|
€228.95M 250.27M USD | €1.00K 1.09K USD | €0.93 1.02 USD | €0.93 1.02 USD | €228.95M 250.27M USD | 0 | -€0.18 -0.1 USD | ||
| Immutep Limited YP1B.F | €0.13 0.15 USD |
+2.31
|
€219.83M 240.31M USD | €49.57K 54.19K USD | €0.13 0.15 USD | €0.13 0.15 USD | €219.83M 240.31M USD | 0 | -€0.02 -0.02 USD | ||
| Armata Pharmaceuticals, Inc. TG1N.F | €5.85 6.39 USD |
-2.5
|
€219.36M 239.8M USD | €1.00K 1.09K USD | €5.85 6.39 USD | €5.85 6.39 USD | €219.36M 239.8M USD | 0 | -€1.44 -1.5 USD | ||
| Immutep Limited YP1A.F | €1.48 1.62 USD |
+2.07
|
€217.84M 238.13M USD | €1.87K 2.05K USD | €1.48 1.62 USD | €1.48 1.62 USD | €217.84M 238.13M USD | 0 | -€0.22 -0.2 USD | ||
| Oncoinvent ASA BRRGF | $0.97 — |
0
|
$237.33M — | $37.31K — | $0.02 — | $0.02 — | $237.33M — | 0 | -$2.04 — | ||
| Genfit S.A. GNFTF | $4.14 — |
0
|
$233.89M — | $100.00 — | $4.14 — | $4.14 — | $233.89M — | 0 | -$0.90 — | ||
| Genfit S.A. XUP.SG | €3.89 4.25 USD |
+4.34
|
€207.40M 226.71M USD | €0.00 0 USD | €3.76 4.11 USD | €3.89 4.25 USD | €207.40M 226.71M USD | 0 | -€0.78 -0.8 USD | ||
| MediWound Ltd. M8W.F | €15.50 16.94 USD |
+6.16
|
€202.17M 221M USD | €942.00 1.03K USD | €15.50 16.94 USD | €15.50 16.94 USD | €202.17M 221M USD | 0 | -€1.60 -1.7 USD | ||
| Editas Medicine, Inc. 8EM.F | €2.04 2.23 USD |
-2.86
|
€199.24M 217.8M USD | €20.00K 21.86K USD | €2.04 2.23 USD | €2.12 2.32 USD | €199.24M 217.8M USD | 0 | -€2.04 -2.2 USD | ||
| Genor Biopharma Holdings Limited 67N0.F | €0.36 0.39 USD |
+0.56
|
€199.14M 217.68M USD | €3.06K 3.34K USD | €0.36 0.39 USD | €0.36 0.39 USD | €199.14M 217.68M USD | 35.60 | €0.01 0.01 USD | ||
| Atrys Health, S.A. A2T.F | €2.54 2.78 USD |
+0.79
|
€199.10M 217.65M USD | €630.00 688.68 USD | €2.35 2.57 USD | €2.54 2.78 USD | €199.10M 217.65M USD | 0 | -€0.32 -0.3 USD | ||
| BioInvent International AB (publ) BOVNF | $3.29 — |
0
|
$216.40M — | $908.00 — | $4.70 — | $4.70 — | $216.40M — | 0 | -$0.47 — | ||
| Genfit S.A. XUPB.MU | €3.90 4.26 USD |
0
|
€197.95M 216.39M USD | €0.00 0 USD | €3.90 4.26 USD | €3.90 4.26 USD | €197.95M 216.39M USD | 0 | -€0.78 -0.8 USD | ||
| Egetis Therapeutics AB (publ) P0F.F | €0.46 0.5 USD |
+2.7
|
€197.57M 215.97M USD | €20.00K 21.86K USD | €0.46 0.5 USD | €0.46 0.5 USD | €197.57M 215.97M USD | 0 | -€0.09 -0.09 USD | ||
| ProQR Therapeutics N.V. 0PQ.F | €1.86 2.03 USD |
+6.1
|
€195.94M 214.19M USD | €758.00 828.6 USD | €1.86 2.03 USD | €1.86 2.03 USD | €195.94M 214.19M USD | 0 | -€0.41 -0.4 USD | ||
| SELLAS Life Sciences Group, Inc. RXK3.F | €1.31 1.43 USD |
-2.53
|
€194.43M 212.54M USD | €14.56K 15.91K USD | €1.31 1.43 USD | €1.31 1.43 USD | €194.43M 212.54M USD | 0 | -€0.24 -0.2 USD | ||
| Voyager Therapeutics, Inc. VT6.F | €3.38 3.7 USD |
-2.7
|
€193.74M 211.78M USD | €150.00 163.97 USD | €3.38 3.7 USD | €3.38 3.7 USD | €193.74M 211.78M USD | 0 | -€1.89 -2.06 USD | ||
| Achieve Life Sciences, Inc. SP4P.F | €3.60 3.94 USD |
+7.14
|
€191.64M 209.49M USD | €5.34K 5.84K USD | €3.37 3.68 USD | €3.60 3.94 USD | €191.64M 209.49M USD | 0 | -€1.17 -1.2 USD | ||
| BioInvent International AB (publ) 0H22.IL | SEK 30.10 2.94 USD |
+0.33
|
SEK 2.12B 206.73M USD | SEK 303.00 29.58 USD | SEK 29.60 2.89 USD | SEK 29.60 2.89 USD | SEK 2.12B 206.73M USD | 0 | -SEK 5.01 -0.4 USD | ||
| Genfit S.A. XUPB.F | €3.64 3.98 USD |
+2.25
|
€188.98M 206.58M USD | €840.00 918.23 USD | €3.64 3.98 USD | €3.64 3.98 USD | €188.98M 206.58M USD | 0 | -€0.78 -0.8 USD | ||
| VitaSpring Biomedical VSBC | $1.00 — |
0
|
$206.52M — | $63.00 — | $0.50 — | $0.50 — | $206.52M — | 0 | $0.00 — | ||
| Genfit S.A. XUP.F | €3.75 4.1 USD |
+2.4
|
€188.55M 206.11M USD | €200.00 218.63 USD | €3.75 4.1 USD | €3.77 4.12 USD | €188.55M 206.11M USD | 0 | -€0.78 -0.8 USD | ||
| Innate Pharma S.A. IPHYF | $2.00 — |
0
|
$197.12M — | $125.00 — | $1.58 — | $1.62 — | $197.12M — | 0 | -$0.63 — | ||
| BioInvent International AB (publ) BIX0.F | €2.67 2.92 USD |
+2.3
|
€180.00M 196.76M USD | €3.00 3.28 USD | €2.67 2.92 USD | €2.67 2.92 USD | €180.00M 196.76M USD | 0 | -€0.45 -0.4 USD | ||
| Egetis Therapeutics AB (publ) P0F.SG | €0.43 0.47 USD |
-7.39
|
€179.93M 196.69M USD | €0.00 0 USD | €0.43 0.47 USD | €0.47 0.51 USD | €179.93M 196.69M USD | 0 | -€0.09 -0.09 USD | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||